GlassScriptPhysician profile
Bharathi T Reddy
NPI 1932292976
$3,243.23
in general payments reported to CMS, 2019-2025
12 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $134 · 2021: $683 · 2022: $548 · 2023: $700 · 2024: $433 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $528.99 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $476.77 | 2019-2022 | |
| Lilly USA, LLC | $342.96 | 2022-2023 | Mounjaro |
| Novo Nordisk INC | $282.10 | 2021-2024 | Ozempic, Rybelsus |
| Cequr Corporation | $264.15 | 2023-2024 | Cequr Simplicity |
| Abbott Laboratories | $249.11 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $242.22 | 2025 | |
| Intuity Medical INC | $235.33 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Glaxosmithkline, LLC. | $227.89 | 2021-2023 | |
| Dexcom, INC. | $144.01 | 2024 | Dexcom G7 Gss (161) |
| Vifor Pharma, INC. | $125.00 | 2019 | |
| Horizon Therapeutics Plc | $124.70 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharathi Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.